Access in Mexico

Latin America ยท Tier 2

Regulatory framework

Mexico's COFEPRIS operates a named-patient framework for specialty drugs.

Typical timeline

For patients in Mexico requesting a specialty drug through {Reserve Meds}, the end-to-end timeline from initial request to drug delivery typically ranges 2-8 weeks. Timing depends on the specific drug, the clinical justification, and destination-regulator review pace.

What a typical process looks like

  1. Patient or physician submits a request with drug name and indication.
  2. We verify clinical appropriateness and document eligibility.
  3. Treating physician issues prescription and clinical justification.
  4. Country-specific regulatory documentation is prepared and submitted.
  5. Patient pre-pays; we source via DSCSA-compliant US wholesaler.
  6. Drug ships cold-chain to destination physician or hospital pharmacy.
  7. Physician receives, confirms storage, and begins treatment.

Popular drug requests from Mexico

Lenmeldy

Metachromatic leukodystrophy

Kresladi

Leukocyte adhesion deficiency I

Elevidys

Duchenne muscular dystrophy

Lyfgenia

Sickle cell disease

Zevaskyn

Recessive DEB

Skysona

Cerebral adrenoleukodystrophy

Casgevy

Sickle cell disease; transfusion-dependent beta-thalassemia

Ryoncil

Pediatric SR-aGvHD

Tecelra

Synovial sarcoma

Encelto

Macular telangiectasia type 2

Qfitlia

Hemophilia A/B prophylaxis

Vyjuvek

Dystrophic epidermolysis bullosa

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (dispensed by Altima Care, US-licensed specialty pharmacy) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp